HomeCompareAPNHY vs NNN

APNHY vs NNN: Dividend Comparison 2026

APNHY yields 1.60% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNN wins by $3.5K in total portfolio value· pulled ahead in Year 6
10 years
APNHY
APNHY
● Live price
1.60%
Share price
$7.63
Annual div
$0.12
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.0K
Annual income
$177.25
Full APNHY calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — APNHY vs NNN

📍 NNN pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPNHYNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APNHY + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APNHY pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APNHY
Annual income on $10K today (after 15% tax)
$135.84/yr
After 10yr DRIP, annual income (after tax)
$150.66/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, NNN beats the other by $2,078.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APNHY + NNN for your $10,000?

APNHY: 50%NNN: 50%
100% NNN50/50100% APNHY
Portfolio after 10yr
$23.7K
Annual income
$1,399.96/yr
Blended yield
5.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

APNHY
No analyst data
Altman Z
2.0
Piotroski
5/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APNHY buys
0
NNN buys
2
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$NNN▼ Sell$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$NNN▲ Buy$1,001 - $15,0002025-06-17
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002023-05-25
Ro Khanna🏢 House$NNN▼ Sell$1,001 - $15,0002022-01-20
Zoe Lofgren🏢 House$NNN▲ Buy$1,001 - $15,0002021-09-30
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002020-03-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPNHYNNN
Forward yield1.60%5.66%
Annual dividend / share$0.12$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$22.0K$25.5K
Annual income after 10y$177.25$2,622.67
Total dividends collected$1.7K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: APNHY vs NNN ($10,000, DRIP)

YearAPNHY PortfolioAPNHY Income/yrNNN PortfolioNNN Income/yrGap
1$10,860$159.82$10,735$614.96+$125.00APNHY
2$11,782$162.20$11,572$708.43+$210.00APNHY
3$12,771$164.47$12,531$819.53+$240.00APNHY
4$13,832$166.61$13,633$952.29+$199.00APNHY
5$14,969$168.64$14,909$1,111.84+$60.00APNHY
6← crossover$16,187$170.57$16,392$1,304.77$205.00NNN
7$17,493$172.38$18,129$1,539.52$636.00NNN
8$18,891$174.10$20,173$1,827.08$1.3KNNN
9$20,390$175.72$22,597$2,181.81$2.2KNNN
10$21,994$177.25$25,491$2,622.67$3.5KNNN

APNHY vs NNN: Complete Analysis 2026

APNHYStock

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

Full APNHY Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this APNHY vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APNHY vs SCHDAPNHY vs JEPIAPNHY vs OAPNHY vs KOAPNHY vs MAINAPNHY vs ADCAPNHY vs EPRTAPNHY vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.